top stories

A new era of treat­ment: How bio­mark­ers are chang­ing the way we think about can­cer

22 hours ago
R&D
In Focus

Mod­er­na chief Ban­cel to do­nate about $355M worth of ear­ly stock to char­i­ty

16 hours ago
People
Pharma

GSK avoids strike as UK work­ers ac­cept pay ne­go­ti­a­tion

17 hours ago
Pharma

Latest

'Hands may be tied': FDA slaps Ver­ri­ca with 3rd CRL due to prob­lems with con­tract man­u­fac­tur­er

23 minutes ago
FDA+

Bris­tol My­ers Squibb sues No­var­tis for roy­al­ties sur­round­ing the use of trans­genic mice

16 hours ago
Pharma
Law

West Vir­ginia man faces prison time for threat­en­ing emails to Fau­ci, oth­er health of­fi­cials

16 hours ago
People
Pharma

Phar­ma com­pa­ny con­tin­ues its FDA law­suit spree, this time af­ter agency de­nies fast-track des­ig­na­tion

16 hours ago
FDA+
see latest stream
People

Geno­cea reach­es end of road, delist­ing from Nas­daq and let­ting go of re­main­ing staff

19 hours ago

French pres­i­dent names Stéphane Ban­cel a Cheva­lier for Mod­er­na's Covid tri­umph

4 days ago

Mod­er­na chair­man Noubar Afeyan de­fends vet­ting process in wake of CFO scan­dal — re­port

5 days ago
Financing

A new spin­out wades in­to ovar­i­an ag­ing, armed with a seed round and ex­per­i­men­tal drugs from Mass Gen­er­al

4 days ago

Scoop: Af­ter pulling IPO am­bi­tions last De­cem­ber, Jeff Aron­in's Cas­tle Creek turns to pri­vate back­ers

4 days ago

Mary­land of­fers loan to Clene de­spite ALS tri­al bumps

5 days ago
Startups

They sold their last biotech to Mer­ck. Now they're back with a PARP out­fit named af­ter a Lon­don street

19 hours ago

Not one, not two, but three — biotech claims it will pur­sue CARs T, M and NK all at once

5 days ago

UP­DAT­ED: Flag­ship builds a new start­up out of pieces from 2 of its biotechs. And a Roche vet leaves to do some­thing ...

6 days ago
Deals

As GSK-part­nered Covid an­ti­body racks up glob­al sales, Vir ax­es WuXi deal and grabs back Chi­na rights

Yesterday

Al­con takes a crack at multi­bil­lion-dol­lar dry eye mar­ket, picks up 2 drugs from Langer spin­out

2 days ago

All Blue's $733M bid to ac­quire Zymeworks turns hos­tile as board bat­tles back — af­ter a biotech celebri­ty jumps in

4 days ago

Premium storiesSee all

Sci­en­tists are fi­nal­ly learn­ing how to de­sign pro­teins from scratch. Drug de­vel­op­ment may nev­er be the same

Last week
People
Discovery

Ex­clu­sive: No­vo Nordisk al­lies it­self with one of the buzzi­est groups in biotech, launch­ing a mul­ti-pronged at­tack at ...

3 weeks ago
Deals
R&D

Is this Sil­i­con Val­ley duo the fu­ture of biotech?

3 weeks ago
People
AI

Con­gress mulls soft­er ac­cel­er­at­ed ap­proval re­forms as part of user fee reau­tho­riza­tions

3 weeks ago
R&D

In FocusSee all

Can this tick bi­ol­o­gist and her team of ‘weirdo sci­ence’ en­thu­si­asts change the fu­ture of sci­en­tif­ic re­search?

4 weeks ago
People
Discovery

'Em­pa­thy and love were not shown’: The sto­ry be­hind Taysha’s lay­offs, one of dozens of biotechs suf­fer­ing this ...

Last month
Cell/Gene Tx

Af­ter Covid-19 suc­cess, pa­tients with the world’s ‘most stig­ma­tized’ in­fec­tion push for their own Op­er­a­tion ...

Last month

Chirps, chats and Club­hous­es: First-time biotech founders turn to so­cial me­dia for ad­vice, in­vestors and re­cruit­ment

Last month
Startups

Don't missSee all

Mod­er­na seeks to dis­miss Al­ny­lam suit over Covid-19 vac­cine com­po­nent, claim­ing wrong venue

17 hours ago
Coronavirus
Law

Cracks in the fa­cade: Is phar­ma's pan­dem­ic ‘feel good fac­tor’ wan­ing?

18 hours ago
Pharma
Marketing

UP­DAT­ED: Plan­ning ahead for crowd­ed ul­cer­a­tive col­i­tis mar­ket, Pfiz­er spells out PhI­II da­ta on $6.7B Are­na drug

20 hours ago
R&D

Man­u­fac­tur­ing con­cerns spur clin­i­cal hold on small biotech's Alzheimer's tri­al — shares plunge

23 hours ago
FDA+

Endpoints Standouts

Sci­en­tists are fi­nal­ly learn­ing how to de­sign pro­teins from scratch. Drug de­vel­op­ment may nev­er be the same

Last week
People
Discovery

The 20(+1) un­der 40: Your guide to the next gen­er­a­tion of biotech lead­ers

Last month
Special

The 2022 top 100 bio­phar­ma in­vestors: A look back on boom times

3 months ago
Financing
Deals

Spe­cial re­port: Meet 20 ex­tra­or­di­nary women who are su­per­charg­ing bio­phar­ma R&D

5 months ago
People
Special

Peer review See all

May
20

Ex-Take­da ex­ec hits the ground run­ning at the helm of rare dis­ease biotech — with 3 pri­or­i­ties off the bat; ...

May
13

Hel­lo, I must be go­ing: Jorge Gomez is Mod­er­na CFO for on­ly a day; As set­backs mount, In­ovio’s Joseph Kim choos­es ...

May
6

With Aduhelm in tat­ters, the search is on for Michel Vounatsos' re­place­ment at Bio­gen; David Liu, Roger Perl­mut­ter ...

Apr
29

‘Nat­ur­al evo­lu­tion’: Caris­ma’s sci­en­tif­ic co-founder moves in­to the CSO post; Vas Narasimhan en­lists Ron­ny Gal ...

Apr
22

Mov­ing on from Us­ama Ma­lik's in­sid­er trad­ing im­broglio, Fore re­sets at the top; Take­da spin­out turns to Neu­rana CEO ...

Pharma channel feed

Yesterday

Co­pay coupons gone wrong, again: Pfiz­er pays al­most $300K to set­tle com­plaints in four states

Pfiz­er has agreed to pay $290,000 to set­tle al­le­ga­tions of ques­tion­able co­pay coupon prac­tices in Ari­zona, Col­orado, Kansas, and Ver­mont from 2014 to 2018.

READ MORE

Delaware court rules against Gilead and Astel­las in years-long patent case

Yesterday
Law

Mer­ck KGaA pumps €440M in­to ex­pand­ing and con­struct­ing Irish man­u­fac­tur­ing fa­cil­i­ties

Yesterday
Manufacturing
latest in Pharma

Lil­ly's mirik­izum­ab, once a con­tender for pso­ri­a­sis, bol­sters case for UC in­di­ca­tion in main­te­nance tri­al da­ta read­out

Yesterday
R&D

No­var­tis li­cens­es out leukemia drug as part of new glob­al coali­tion to in­crease ac­cess to can­cer treat­ments

Yesterday

Bris­tol My­ers dusts off an old Cel­gene chemother­a­py for use in chil­dren with a rare blood can­cer

Yesterday
FDA+

House Dems to Sen­ate lead­er­ship: Quick­ly move a rec­on­cil­i­a­tion bill with drug price ne­go­ti­a­tion re­forms

Yesterday

This year's For­tune 500 list is out. And phar­ma com­pa­nies saw ma­jor prof­it growth

Yesterday
see latest stories

Marketing channel feed

Yesterday

Idor­sia inks an­oth­er celebri­ty en­dors­er deal with ac­tor and dad Taye Dig­gs as Qu­viviq in­som­nia am­bas­sador

Idor­si­a's lat­est Qu­viviq in­som­nia cam­paign de­tails the re­lat­able dad sto­ry of a well-known celebri­ty — ac­tor and Broad­way star Taye Dig­gs.

READ MORE

Pfiz­er teams up with dig­i­tal ther­a­peu­tics part­ner for next prod­uct launch, this time in atopic der­mati­tis

5 days ago
Deals

Mar­ket­ingRx roundup: GSK in­vites al­ler­gy suf­fer­ers to cre­ate cus­tom mon­sters; Merz kicks off soc­cer spon­sor­ship

18 hours ago
Pharma
latest in Marketing

GSK re-ups menin­gi­tis B cam­paign with pop­u­lar ‘80s child ac­tor, now a mom of 4

4 days ago
Pharma

What drug cat­e­gories spend the most on ad­ver­tis­ing? Di­a­betes, pso­ri­a­sis and arthri­tis top the list

4 days ago
Pharma

Gilead leads HIV grant­mak­ers list, tops Gates Foun­da­tion in a first for an­nu­al sur­vey

5 days ago
Pharma

J&J opens up con­ver­sa­tions around de­pres­sion in the LGBTQ+ com­mu­ni­ty with new cam­paign

6 days ago
Pharma

Ab­b­Vie ex­pands use of re­al pa­tients in lat­est Al­ler­gan Aes­thet­ics DTC cam­paign

6 days ago
Pharma
see latest stories

FDA+ channel feed

Yesterday

House Re­pub­li­cans at­tack Chi­na-on­ly da­ta in FDA sub­mis­sions, seek new in­ves­ti­ga­tion in­to re­search in­spec­tions

Three Re­pub­li­can rep­re­sen­ta­tives are call­ing on the FDA to take a clos­er look at the ap­pli­ca­tions in­clud­ing on­ly clin­i­cal da­ta from Chi­na.

READ MORE

'I re­al­ly don’t look back': Janet Wood­cock on her tran­si­tion away from drugs

Yesterday

Sanofi and Re­gen­eron clear the fin­ish line in an in­flam­ma­to­ry esoph­a­gus dis­ease, leav­ing Take­da in the dust

4 days ago
Pharma
latest in FDA+

With top­i­cal ap­proval, Der­ma­vant looks to bring new stan­dard-of-care to plaque pso­ri­a­sis pa­tients

21 hours ago

FDA calls for non­in­fe­ri­or­i­ty tri­als for an­tibac­te­ri­als, thanks to new drugs for re­sis­tant in­fec­tions

Yesterday

Try­ing to shake up the Parkin­son's par­a­digm, Ab­b­Vie sub­mits NDA for con­tin­u­ous, 24-hour in­fu­sion ther­a­py

4 days ago
R&D

Sanofi's $20B buy­out of Gen­zyme pays off again with Eu­ro­pean OK for first Nie­mann-Pick drug

4 days ago

Flag­ship's Foghorn, part­nered with Mer­ck and Eli Lil­ly, gets a par­tial FDA hold af­ter pa­tient death

4 days ago
R&D
see latest stories

Manufacturing channel feed

Yesterday

UP­DAT­ED: On the back of SIGA Tech­nolo­gies' win with the FDA, the mon­key­pox virus sees the com­pa­ny spring­ing to fur­ther ac­tion

As the cas­es of mon­key­pox now sit at well over 100 world­wide and have spread to mul­ti­ple con­ti­nents, the or­ders for any type of vac­cine against mon­key­pox are see­ing na­tions and med­ical ...

READ MORE

Fu­ji­film con­tin­ues its biotech build­ing spree with new fa­cil­i­ty in Chi­na

4 days ago
China
Pharma

Proac­tive­ly pre­vent­ing short­ages: New FDA guid­ance spells out which drugs re­quire risk man­age­ment plans

5 days ago
FDA+
latest in Manufacturing

Af­ter pri­vate and state in­vest­ment, Am­pli­fy­Bio plans to ex­pand to an­oth­er Colum­bus, OH lo­ca­tion

19 hours ago
Outsourcing

SQZ's out­side-the-box man­u­fac­tur­ing method slash­es pro­duc­tion time in ear­ly in study

5 days ago
Pharma

Catal­ent in­tro­duces new AAV gene ther­a­py tech in aim to speed up man­u­fac­tur­ing process

5 days ago
Pharma

With new ac­qui­si­tion, Bo­ra to ven­ture in­to bi­o­log­ics

5 days ago
Pharma

Re­silience inks man­u­fac­tur­ing pact with ARCH-backed cell ther­a­py start­up as it preps for the long haul

5 days ago
Deals
see latest stories